Neonatal and Pediatric Medicine
Open Access

Neonatal infections are a leading cause of morbidity and mortality among newborns. Maternal vaccination has emerged as a critical public health intervention to reduce the incidence of these infections. By vaccinating pregnant women, it is possible to confer passive immunity to the neonate, thus providing protection during the vulnerable early months of life.

1. Early-onset neonatal infections: These occur within the first 72 hours of life and are usually acquired during labor and delivery. Common pathogens include:

• Group B Streptococcus (GBS): One of the most common causes of early-onset sepsis.
• Escherichia coli (E. coli): Another frequent cause, often associated with premature rupture of membranes.
• Listeria monocytogenes: Can be transmitted through contaminated food consumed by the mother during pregnancy.

2. Late-onset neonatal infections: These occur after the first 72 hours of life and are often acquired from the environment or through hospital contact. Common pathogens include:

• Staphylococcus aureus, including Methicillin-resistant Staphylococcus aureus (MRSA).
• Candida species: Yeast infections that can occur in the bloodstream.
• Pseudomonas aeruginosa: Often associated with healthcare settings.

Mechanisms of protection

Maternal vaccines work primarily through the transfer of antibodies from the mother to the fetus via the placenta. This passive immunity provides the newborn with immediate protection against specific pathogens [1]. Additionally, maternal vaccination can reduce the burden of disease in the community, indirectly protecting newborns.

Vaccines and Their Impact

Influenza vaccine

The influenza vaccine is recommended for pregnant women to protect against seasonal flu. Studies have shown that maternal influenza vaccination significantly reduces the risk of influenza and its complications in infants during the first six months of life. For example, a study published in The New England Journal of Medicine demonstrated a 63% reduction in influenza-related hospitalizations among infants whose mothers received the flu vaccine during pregnancy.

Tdap Vaccine (Tetanus, Diphtheria, Pertussis)

Maternal vaccination with Tdap is crucial for preventing pertussis (whooping cough) in newborns, a disease that can be severe in infants. Evidence from multiple studies, including those reviewed in The Lancet Infectious Diseases, indicates that maternal Tdap vaccination provides high levels of protection against pertussis during the first few months of life [2-4]. The vaccine is recommended during the third trimester of each pregnancy.

Hepatitis B Vaccine

Although not always administered during pregnancy, the hepatitis B vaccine plays a role in preventing maternal transmission of the virus to the infant. Pregnant women who are hepatitis B positive are recommended to receive antiviral therapy to reduce the risk of transmission. Infants born to hepatitis B-positive mothers receive the hepatitis B vaccine and hepatitis B immune globulin (HBIG) within 12 hours of birth.

COVID-19 Vaccine

The COVID-19 vaccines have been a major focus in recent years. Data suggest that maternal COVID-19 vaccination can provide protection to neonates against severe COVID-19 illness. Research published in JAMA and The Lancet shows that maternal vaccination is associated with reduced risk of severe outcomes and high antibody levels in infants.

Challenges and Considerations

While maternal vaccination is highly effective, several challenges persist:

• Vaccine hesitancy: Misconceptions about vaccine safety during pregnancy can impact vaccination rates.
• Vaccine coverage: Ensuring high coverage rates among pregnant women is essential for maximizing public health benefits [5].
• Side effects and safety: Continuous monitoring of vaccine safety during pregnancy is crucial to address any concerns and ensure the well-being of both mother and baby.

Risk Factors

• Prematurity: Preterm infants have underdeveloped immune systems and are more susceptible to infections.
• Low birth weight: Babies with a low birth weight may have compromised immune defenses.
• Maternal factors: Maternal infections, poor prenatal care, or conditions such as diabetes can increase the risk.
• Invasive procedures: Use of catheters, mechanical ventilation, or other invasive techniques can introduce pathogens.

Future Directions

Future research should focus on:

• Expanding vaccine recommendations: Investigating additional vaccines that could benefit maternal and neonatal health [6-8].
• Enhancing vaccine delivery: Improving strategies to increase vaccination rates among pregnant women.
• Long-term outcomes: Studying the long-term effects of maternal vaccination on child health.

Conclusion

Maternal vaccination is a key component in the prevention of neonatal infections. Current evidence supports the effectiveness of vaccines like influenza, Tdap, hepatitis B, and COVID-19 in protecting newborns from serious infections. Continued efforts are needed to improve vaccine coverage and address challenges to further enhance the health outcomes of both mothers and their infants. Neonatal infections are a serious concern but can often be managed effectively with timely intervention. If you suspect a newborn might have an infection, it's crucial to seek medical attention immediately.

1. Ocheke IE, Antwi S, Gajjar P, McCulloch MI, Nourse P (2014)Pelvi-ureteric junction obstruction at Red Cross Children’s Hospital, Cape Town:a six year review.Arab J Nephrol Trans 7: 33-36.

Indexed at,Google Scholar

2. Capello SA, Kogan BA, Giorgi LJ (2005)Kaufman RP. Prenatal ultrasound has led to earlier detection and repair of ureteropelvic junction obstruction.J Urol 174: 1425-1428.

Google Scholar,Crossref

3. Johnston JH, Evans JP, Glassberg KI, Shapiro SR (1977)Pelvic hydronephrosis in children: a review of 219 personal cases.J Urol 117: 97-101.

Google Scholar,Crossref

4. Williams DI, Kenawi MM (1976)The prognosis of pelviureteric obstruction in childhood: a review of 190 cases.Eur Urol 2: 57-63.

Google Scholar,Crossref

5. Lebowitz RL, Griscom NT (1977) Neonatal hydronephrosis: 146 cases. Radiol Clin North Am 15: 49-59.

Indexed at,Google Scholar

6. Hubertus J, Plieninger S, Martinovic V, Heinrich M, Schuster T, et al. (2013)Children and adolescents with ureteropelvic junction obstruction: is an additional voiding cystourethrogram necessary? Results of a multicenter study.Wor J Urol 31: 683-687.

Indexed at,Google Scholar,Crossref

7. Swenson DW, Darge K, Ziniel SI, Chow JS (2015)Characterizing upper urinary tract dilation on ultrasound: a survey of North American pediatric radiologists’ practices. Pedia Radiol 45: 686-694.

Google Scholar,Crossref

8. Hussain, Walid A, Jeremy D (2019)Approaches to Noninvasive Respiratory Support in Preterm Infants: From CPAP to NAVA.NeoReviews 20: 213–221.

Indexed at,Google Scholar,Crossref